Patents/Assignees

Inflarx GmbH

4 patents in portfolio

US12606613utility2026
Humanized Anti-c5a Antibodies
0 cites
US12180274utility2024
Treatment of Pneumonia and ARDS with Inhibitors of C5a and IL-6 Activity
0 cites
US11999698utility2024
Fused Piperidinyl Bicyclic and Related Compounds as Modulators of C5a Receptor
0 cites
US11890349utility2024
Treatment of Inflammatory Diseases with Inhibitors of C5A Activity
0 cites